Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
1.
Arch. Soc. Esp. Oftalmol ; 99(1): 9-15, enero 2024. tab, graf
Article in Spanish | IBECS | ID: ibc-229547

ABSTRACT

Objetivo: Traducir y validar al castellano el cuestionario V-FUCHS en una población de pacientes que padecen distrofia endotelial de Fuchs (DEF).MétodosEl V-FUCHS consta de 15 preguntas, que valoran aspectos visuales de la calidad de vida en los pacientes con DEF, las cuales se pueden agrupar en 7 que valoran el factor «dificultad visual» y 8 que valoran el factor «deslumbramiento». Para la traducción y adaptación se siguieron las normas estandarizadas, destacando, una traducción, una retro-traducción y una aplicación en pacientes con DEF.ResultadosEn una primera fase se llegó al consenso de la traducción al castellano del V-FUCHS. Posteriormente, se incluyeron 25 pacientes para realizar la fase pre-test con el objetivo de valorar la aplicabilidad y la viabilidad del test. La puntuación de las mismas obtuvo un valor mínimo de −0,88 y un valor máximo de +2,44, según la escala probabilística de Rasch. El valor medio obtenido de las preguntas que conforman el factor dificultad visual fue de 0,61 (±0,71) y la media del factor deslumbramiento (Glare) fue de 0,41 (±0,51).ConclusiónLa validación del cuestionario V-FUCHS, tras su traducción y adaptación al castellano, demostró ser una herramienta útil para la valoración de la calidad visual de los pacientes con DEF. Los pacientes con un estado más avanzado de la enfermedad presentaron una mayor severidad en el resultado de la prueba. Asimismo, el factor deslumbramiento se correlaciona mejor con el aumento paquimétrico que con la agudeza visual del paciente. (AU)


Purpose: To translate and validate the V-FUCHS questionnaire into Spanish in a population of patients with Fuchs endothelial dystrophy (DEF).MethodsThe V-FUCHS consists of 15 short, easily understandable questions that assess visual aspects of quality of life in patients with DEF, which can be gathered into a group of seven that assess the “Visual Difficulty” factor and another group of eight that assess the “Glare Factor”. For the translation and cultural adaptation, the standardized norms for this process were followed, among other phases, a translation, a back-translation and an application in patients with DEF.ResultsIn the first phase, consensus was reached on the Spanish translation of the V-FUCHS. Subsequently, 25 patients were included to carry out the pre-test phase with the aim of assessing the applicability and feasibility of the test. The score obtained a minimum value of −0.88 and a maximum value of +2.44, according to the Rasch probabilistic scale. The mean value obtained from the Visual Difficulty factor was 0.61 (±0.71), while the mean for the Glare factor was 0.41 (±0.51).ConclusionThe validation of the V-FUCHS questionnaire, after its translation and adaptation into Spanish, proved to be a useful tool for assessing the visual quality of patients with DEF. Patients with a more advanced stage of the disease presented a greater severity in the test result. Likewise, the Glare factor (Glare) correlates better with the pachymetric increase than with the visual acuity of the patient. (AU)


Subject(s)
Humans , Cornea , Fuchs' Endothelial Dystrophy , Health Status , Quality of Life , Surveys and Questionnaires
2.
Arch Soc Esp Oftalmol (Engl Ed) ; 99(1): 9-15, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37944642

ABSTRACT

PURPOSE: To translate and validate the V-FUCHS questionnaire into Spanish in a population of patients with Fuchs endothelial dystrophy (DEF). METHODS: The V-FUCHS consists of 15 short, easily understandable questions that assess visual aspects of quality of life in patients with DEF, which can be gathered into a group of seven that assess the "Visual Difficulty" factor and another group of eight that assess the "Glare Factor". For the translation and cultural adaptation, the standardized norms for this process were followed, among other phases, a translation, a back-translation and an application in patients with DEF. RESULTS: In the first phase, consensus was reached on the Spanish translation of the V-FUCHS. Subsequently, 25 patients were included to carry out the pre-test phase with the aim of assessing the applicability and feasibility of the test. The score obtained a minimum value of -0.88 and a maximum value of +2.44, according to the Rasch probabilistic scale. The mean value obtained from the Visual Difficulty factor was 0.61 (±0.71), while the mean for the Glare Factor was 0.41 (±0.51). CONCLUSION: The validation of the V-FUCHS questionnaire, after its translation and adaptation into Spanish, proved to be a useful tool for assessing the visual quality of patients with DEF. Patients with a more advanced stage of the disease presented a greater severity in the test result. Likewise, the Glare Factor (Glare) correlates better with the pachymetric increase than with the visual acuity of the patient.


Subject(s)
Fuchs' Endothelial Dystrophy , Quality of Life , Humans , Cornea , Health Status , Surveys and Questionnaires , Language
3.
Chemosphere ; 65(2): 190-200, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16620908

ABSTRACT

Despite a growing attention to the dissolved organic matter (DOM) in terrestrial ecosystems and evidence of the fact that vegetation affects the quality of both undissolved and dissolved organic matter in soil, the role of DOM as a biological indicator is still poorly understood. In this work, the fertility of 59 sites, divided into eight key alliances of the order Fagetalia sylvaticae Pawl., was studied considering chemical and biological parameters such as soil DOM, hormone-like activity, low-molecular-weight (LMW) aliphatic and phenolic acids, and floristic data. Both non-parametric tests and principal component analysis (PCA) revealed differences between silver fir and beech forests and within each type of forest. There were also differences between neutrophilous and acidophilous types. What's more, PCA reveals the dominance of the auxin (IAA)-like activity, and of some phenolic acids in distinguishing the acidophilous beeches (ACI) form the other types, whereas the gibberellin (GA)-like activity is more relevant in neutrophilous conditions such as thermophilous (THE) and mesophilous (MESO) beeches and montane (MO), high montane (HMA), high montane (HMC) silver fir forests. The GA-like activity is also related to the succinic, fumaric, malonic, and l-malic acids in the MO, HMA and HMC silver fir forests. Moreover, the role of LMW aliphatic acids in mobilizing the hormone-like activity, which improves forest growth, is stressed. The growth of seedlings of Picea abies was influenced by the phenolic acid content. At concentrations between 1 and 100 microM, phenylacetic and protocatechuic acids inhibited root growth to the same extent as indoleacetic acid, while p-hydroxybenzoic acid had a stimulating effect comparable to that of gibberellic acid. The aliphatic and phenolic acids appear to be related to plant strategies that influence soil fertility affecting plant growth through rhizodeposition. The role of LMW aliphatic and phenolic acids as molecular markers of ecosystem function is noted.


Subject(s)
Abies/physiology , Fagus/physiology , Fatty Acids/analysis , Hydroxybenzoates/analysis , Organic Chemicals/analysis , Soil Pollutants/analysis , Biological Assay , Ecosystem , Fatty Acids/metabolism , Hormones/analysis , Hormones/metabolism , Hydroxybenzoates/metabolism , Molecular Weight , Organic Chemicals/metabolism , Phenylacetates/analysis , Phenylacetates/metabolism , Plant Roots/chemistry , Plant Roots/metabolism , Soil Pollutants/metabolism , Vanillic Acid/analysis , Vanillic Acid/metabolism
4.
Radiol Med ; 90(3): 272-7, 1995 Sep.
Article in Italian | MEDLINE | ID: mdl-7501833

ABSTRACT

To date, Doppler US has been rarely used to diagnose chronic renal transplant rejection because of its low sensitivity. Nevertheless, all the results have been obtained from the analysis of flow-metric indices, mainly considering the diastolic phase of the Doppler waveform, e.g., the resistance index (RI) and the pulsatility index (PI). This study was aimed at investigating if Doppler diagnostic accuracy in renal transplant monitoring can be increased by studying the systolic phase, considering peak arterial systolic velocity (Vp), acceleration time (AT) and acceleration index (AI). Seventy-six renal transplant recipients were examined with color-Doppler and duplex Doppler US, which showed 47 well-functioning and 29 hypofunctioning kidneys. The diagnosis was confirmed with perfusion scintigraphy with 99mTc DTPA, biopsy and 6-month clinical-laboratory follow-up. The means of Vp, AI, AT and RI relative to the group of patients with normal renal function were compared with those in the group of patients with chronic rejection. Critical values were measured at the segmental arteries (Vp = 70 cm/s, AI = 7 m/s2, AT = 100 ms), at the interlobar arteries (Vp = 45 cm/s, AI = 4 m/s2, AT = 100 ms) and at the arcuate arteries (Vp = 35 cm/s, AI = 3 m/s2, AT = 100 ms). On the basis of these values, normal functioning transplants were differentiated from hypofunctioning ones. RIs were altered (> 0.75) in 8 of 17 chronic rejections and in 3 of 47 normal transplants, with 47.1% sensitivity and 93.6% specificity. The combination of RI with Vp and AI strongly increased both sensitivity (100%) and specificity (82.98%). Combined AI and RI exhibited 94.1% sensitivity and 89.3% specificity. In conclusion, the indices of the ascending systolic phase, in peripheral vascular samplings, are clearly more efficacious than RI alone and index combination exhibits the highest diagnostic accuracy.


Subject(s)
Graft Rejection/diagnostic imaging , Kidney Transplantation/diagnostic imaging , Adult , Aged , Chronic Disease , Creatinine/blood , Female , Follow-Up Studies , Graft Rejection/blood , Graft Rejection/physiopathology , Humans , Kidney Transplantation/physiology , Male , Middle Aged , Radionuclide Imaging , Renal Artery/diagnostic imaging , Renal Artery/physiopathology , Sensitivity and Specificity , Systole , Technetium Tc 99m Pentetate , Ultrasonography, Doppler, Color/instrumentation , Ultrasonography, Doppler, Color/methods , Ultrasonography, Doppler, Color/statistics & numerical data , Ultrasonography, Doppler, Duplex/instrumentation , Ultrasonography, Doppler, Duplex/methods , Ultrasonography, Doppler, Duplex/statistics & numerical data
5.
Int J Artif Organs ; 18(5): 261-3, 1995 May.
Article in English | MEDLINE | ID: mdl-8567102

ABSTRACT

PVC tubes, from the dialysis water distribution system of a 14 and a 7 year old plant, were analysed by scanner electron microscopy (SEM) and X-ray microanalysis (EDAX). Results showed that the leaching of material occurs depending on time of use. The phenomenon does not modify the chemical composition of the material. Results suggest that PVC alterations, induced by time, could support bacterial proliferation thus reducing the quality of dialysate.


Subject(s)
Polyvinyl Chloride/chemistry , Renal Dialysis/standards , Water Purification/standards , Corrosion , Electron Probe Microanalysis , Microscopy, Electron, Scanning , Surface Properties
6.
Int J Artif Organs ; 17(11): 576-80, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7744516

ABSTRACT

This study was performed in 97 hemodialysis patients (85 on HD and 12 on CAPD) to investigate the possible correlation between B2-m and hemodialysis-related amyloidosis syndromes (HRA-S); differences in B2-m and HRA behavior between patients hemodialysed with cellulose and synthetic membranes were also included in the present study. Data indicate that B2-m levels are not correlated with dialysis length or with the type of membrane used for the dialysis. On the contrary, in 16 patients with the Carpal Tunnel Syndrome, a significant correlation was found between the CTS, the dialysis length and the type of membrane (greater incidence with cellulosic membranes).


Subject(s)
Amyloidosis/etiology , Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Renal Dialysis/adverse effects , Uremia/blood , beta 2-Microglobulin/metabolism , Adult , Aged , Amyloidosis/blood , Blood Proteins/metabolism , Carpal Tunnel Syndrome/blood , Carpal Tunnel Syndrome/etiology , Cellulose/chemistry , Cohort Studies , Female , Humans , Male , Membranes, Artificial , Middle Aged , Uremia/therapy
7.
Kidney Int Suppl ; 41: S70-1, 1993 Jun.
Article in English | MEDLINE | ID: mdl-8320949

ABSTRACT

The correction of renal anemia by recombinant human erythropoietin (rHuEPO) makes it possible to assess the effect of anemia on uremic cardiopathy (UC). So far, conflicting results have been reported. We studied 10 hemodialyzed patients aged (51 +/- 18 years, dialytic age 47 +/- 18 months) before and after rHuEPO treatment. All patients underwent an echocardiogram before, and six months after stable hematocrit (31 +/- 2) was obtained. The results show a reduction in LVDD. No improvement in ejection fraction and in ventricular hypertrophy was observed, probably owing to an increase in blood pressure. Finally, there is a possibility that the myocardium of hemodialyzed patients undergoes anatomical changes which may not improve, even after anemia correction.


Subject(s)
Anemia/drug therapy , Erythropoietin/therapeutic use , Heart Diseases/physiopathology , Uremia/complications , Adult , Aged , Anemia/etiology , Female , Heart Diseases/etiology , Heart Diseases/pathology , Humans , Male , Middle Aged , Recombinant Proteins/therapeutic use , Ventricular Function
8.
Nephron ; 61(3): 269-70, 1992.
Article in English | MEDLINE | ID: mdl-1386899

ABSTRACT

From 1986 to 91, 174 dialysis patients were studied. The prevalence of previous HBV infection and of chronic carriers was 33.3 and 4.6%, respectively. Immunization rate after vaccination (3 doses) was 63%. In 1991, we proposed a vaccination with 4 doses and recommend a 6-monthly anti-HBs evaluation to assess the timing of any booster dose needed.


Subject(s)
Hepatitis B/transmission , Renal Dialysis/adverse effects , Aged , Carrier State/prevention & control , Cross Infection/prevention & control , Cross Infection/transmission , Female , Hepatitis B/prevention & control , Hepatitis B Antibodies/blood , Hepatitis B Vaccines , Hepatitis B virus/immunology , Hepatitis, Chronic/prevention & control , Humans , Male , Middle Aged , Viral Hepatitis Vaccines/therapeutic use
9.
Nephron ; 61(3): 278-83, 1992.
Article in English | MEDLINE | ID: mdl-1386900

ABSTRACT

Because of the great problem of viral hepatitis in hemodialysis patients, the Italian Society of Nephrology decided to perform a national epidemiologic survey. We contacted 467 nephrological centers by a questionnaire which let us have information on 25,746 uremic patients: 18,338 on HD, 2,250 on PD and 5,176 with kidney transplant, respectively 78.5% of the total Italian dialysed patients and 91.4% of the total transplanted patients. Statistical analyses were performed. HBV infections occur in 7.8% of the patients (2,008 cases) but considering that 485 cases became spontaneously negative, the true overall incidence of chronic carriers falls to 4.9%. The main causes of the infection are reported as transfusions (64.3%) and dialysis environment (12%). The vaccination program performed by 93.2% of the centers, obtained an efficacious seroconversion in 4,626 of 7,790 cases vaccinated: the vaccine currently most utilized is the recombinant type administered by means of 3 versus 4 boosters. In the 2nd part of the survey, we report information concerning the presence of nephropaties associated with HBV infections in nonuremic patients (208 cases). We present and discuss the clinical picture of the nephropaties, the hystologic bioptic pattern and the prognosis of the kidney pathology.


Subject(s)
Hepatitis B/epidemiology , Renal Dialysis/adverse effects , Carrier State/epidemiology , Cross Infection/epidemiology , Cross Infection/prevention & control , Data Collection , Hepatitis B/prevention & control , Hepatitis B/transmission , Hepatitis B Vaccines , Humans , Italy/epidemiology , Kidney Transplantation/adverse effects , Peritoneal Dialysis/adverse effects , Viral Hepatitis Vaccines/therapeutic use
10.
Nephron ; 61(3): 313-4, 1992.
Article in English | MEDLINE | ID: mdl-1323778

ABSTRACT

In our Dialytic Unit, the prevalence of antibodies to HCV (anti-HCV) was 16.4% in 1990 (73 hemodialyzed) and 21% in 1991 (105 hemodialyzed). The incidence of seroconversion was 13.1%. The transaminase behavior was similar in a group of anti-HCV-positive and a group of anti-HCV-negative patients and with previous HBV infection. Blood transfusions and dialytic age did not affect anti-HCV positivity.


Subject(s)
Hepatitis C/etiology , Renal Dialysis/adverse effects , Adult , Aged , Alanine Transaminase/blood , Aspartate Aminotransferases/blood , Hepacivirus/immunology , Hepatitis Antibodies/blood , Hepatitis C/immunology , Hepatitis C/transmission , Humans , Middle Aged , Risk Factors , Transfusion Reaction
11.
Pharmacol Biochem Behav ; 36(2): 327-31, 1990 Jun.
Article in English | MEDLINE | ID: mdl-1972580

ABSTRACT

The D2 dopamine receptor agonist LY 171555 (0.5 to 5 mg/kg) induces dose-dependent catalepsy in C57BL/6, DBA/2 and BALB/c inbred strains of mice. This effect shows marked strain-dependent differences, since the response of C57BL/6 is significantly lower than those presented by the other two inbred strains at all doses tested. In previous studies we have shown that the D2 agonist at doses ranging from 0.5 to 5 mg/kg induces hyperdefensive responses toward nonaggressive opponents in mice of the C57BL/6 and BALB/c but not of the DBA/2 strain. Here we report that the outbred CD1 mice present both cataleptic and hyperdefensive responses when challenged with LY 171555. Forty-five percent of individuals presenting high defensive response and 11% high cataleptic scores. No correlation was found between catalepsy and hyperdefensiveness in CD1 mice following administration of 1 mg/kg of the D2 agonist. These results suggest that D2 receptor stimulation results in different behavioral responses, possibly mediated by different dopaminergic systems, depending on the genetic make up.


Subject(s)
Catalepsy/chemically induced , Defense Mechanisms , Dopamine Agents/toxicity , Ergolines/toxicity , Receptors, Dopamine/metabolism , Animals , Catalepsy/genetics , Catalepsy/metabolism , Genotype , Male , Mice , Mice, Inbred Strains , Quinpirole , Receptors, Dopamine/genetics , Receptors, Dopamine D2 , Species Specificity
13.
Funct Neurol ; 4(2): 173-5, 1989.
Article in English | MEDLINE | ID: mdl-2737506

ABSTRACT

Twenty subjects suffering from chronic renal failure and undergoing continual treatment by haemodialysis were examined, and the following values assessed: maximum conduction velocity of the sensory and motor fibres of the common peroneal nerve, the relative electromyographic parameters, and the sympathetic skin response at the level of the foot. The results obtained have shown that autonomic neuropathy involving the sympathetic sudomotor is less frequent than sensorimotor neuropathy. The autonomic failures are scanty in the mild forms of sensorimotor neuropathy, with minor latency in the onset of uremia.


Subject(s)
Kidney Failure, Chronic/physiopathology , Sympathetic Nervous System/physiopathology , Adult , Galvanic Skin Response , Humans , Kidney Failure, Chronic/complications , Middle Aged , Motor Neurons/physiology , Neural Conduction , Neurons, Afferent/physiology
16.
Boll Soc Ital Biol Sper ; 61(1): 27-31, 1985 Jan 30.
Article in Italian | MEDLINE | ID: mdl-2983743

ABSTRACT

Serum growth hormone (GH) levels in basal conditions (two samples) and 30, 60, 90, 120, 150 and 180 minutes after oral administration of baclofen (20 mg) were evaluated in 6 healthy subjects and in 6 acromegalic patients. The effect of cimetidine (400 mg i.v.) administrated 45 minutes after baclofen (20 mg by mouth) were evaluated in 9 healthy women. Baclofen was able to significantly rise serum GH levels in normal subjects but no in acromegalic patients. Cimetidine suppress GH increase induced by baclofen. It was concluded that: 1) baclofen, GABAb receptor agonist, stimulate GH secretion by inhibition of GIF secretion or by stimulation of GRF secretion; 2) istamine, through H2 receptors in the hypothalamus, is important to mediate GH release induced by stimulation of GABAb receptors.


Subject(s)
Acromegaly/physiopathology , Baclofen , Growth Hormone/metabolism , Hypothalamo-Hypophyseal System/physiopathology , Receptors, GABA-A/physiology , Adult , Baclofen/pharmacology , Cimetidine , Female , Histamine/physiology , Humans , Male , Pituitary Gland, Anterior/metabolism , Receptors, Histamine H2/physiology
17.
Boll Soc Ital Biol Sper ; 61(1): 33-8, 1985 Jan 30.
Article in Italian | MEDLINE | ID: mdl-2983744

ABSTRACT

Serum prolactin (PRL) levels in basal conditions (two samples) and 30, 60, 90, 120, 150 e 180 minutes after oral administration of baclofen (20 mg) were evaluated in 6 healthy subjects and in 10 patients with prolactinoma. The effect of baclofen (20 mg by mouth) on the PRL secretion cimetidine (400 mg i.v.) or domperidone (20 mg i.v.) induced were evaluated in 9 healthy women by administration of baclofen 60 minutes before cimetidine or domperidone. Baclofen was unable to significantly rise serum PRL levels in healthy subjects and in patients affected by prolactinoma and furthermore did not interfere with PRL rise domperidone induced. On the contrary baclofen decreased PRL rise cimetidine induced. It was concluded that: in basal condition, GABAb receptor don't play an obvious role in modulation of PRL secretion; when H2 istaminergic inhibition on PRL secretion is blocked (at an hypothalamic site), a GABA inhibition, b receptor mediated, on PRL secretion became more clear; the domperidone blockade of hypophysial dopaminergic receptors suggests that GABAb modulation of prolactin secretion don't obtain itself by dopaminergic pathways.


Subject(s)
Baclofen , Hypothalamo-Hypophyseal System/physiopathology , Pituitary Neoplasms/metabolism , Prolactin/metabolism , Receptors, GABA-A/physiology , Adult , Cimetidine , Domperidone , Dopamine/physiology , Drug Interactions , Female , Humans , Male , Pituitary Neoplasms/physiopathology
18.
Minerva Med ; 75(26): 1601-6, 1984 Jun 23.
Article in Italian | MEDLINE | ID: mdl-6738910

ABSTRACT

Eighteen patients aged between 14 and 60 years suffering from diabetes insipidus were studied. Diabetes insipidus was diagnosed by means of Robertson's test. All patients underwent C.T. scanning and evaluation of PRL basally and after TRH (200 mcg e.v.). Twelve patients (66%) showed neurological lesions (secondary central diabetes insipidus). Six of these patients had hyperprolactinaemia. Our data suggest that most of central diabetes insipidus are associated with central system nervous (S.N.C.) damage. In same cases the presence of hyperprolactinaemia suggests a brain damage. Therefore neuroradiological study is very important in all cases of neurohypophyseal diabetes insipidus.


Subject(s)
Diabetes Insipidus/physiopathology , Hypopituitarism/complications , Pituitary Gland, Posterior/physiopathology , Adolescent , Adult , Diabetes Insipidus/etiology , Diabetes Insipidus/metabolism , Female , Humans , Male , Middle Aged , Pituitary Gland, Posterior/metabolism , Pituitary Neoplasms/complications , Prolactin/blood , Prolactin/metabolism , Vasopressins/blood , Vasopressins/metabolism
19.
Boll Soc Ital Biol Sper ; 60(4): 783-7, 1984 Apr 30.
Article in Italian | MEDLINE | ID: mdl-6428436

ABSTRACT

6 women (mean age 38 years) with high Thyroid Stimulating Hormone (TSH) serum levels because affected from primary hypothyroidism were studied. 6 healthy women (mean age 31 years) represented the control group. All subjects underwent evaluation of serum TSH, Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), basally and 20, 30, 60, 120 minutes after administration of Gonadotropin Releasing Hormone (GnRH: 100 meg. IV). Seric FSH and LH show a large increase 30 minutes after GnRH either in healthy or in hypothyroid subjects. TSH is unresponsive to GnRH in normal condition, while shows a clear decrease (-78%) 30 minutes after GnRH in primary hypothyroidism. Rarely the hypothalamic releasing hormones possess an inhibitory effect on anteipophyseal secretions. Previously a GnRH inhibitory effect on prolactin (PRL) release from PRL secreting tumors in rat. The GnRH inhibitory effect on TSH release in pathological conditions such as primary hypothyroidism is difficult to explain: it may be that GnRH acts on Central Nervous System or at pituitary level: in the last case it could bind sites which are not quite different in the different glycoprotein secreting cells.


Subject(s)
Gonadotropin-Releasing Hormone , Hypothyroidism/blood , Thyrotropin/blood , Adult , Female , Follicle Stimulating Hormone/blood , Humans , Luteinizing Hormone/blood , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...